Articles From: EnteroMedics Reports Third Quarter 2014 Financial Results to KP Tissue Releases Third Quarter 2014 Financial Results


Company to Host Conference Call Today, November 12, 2014, at 11:00 AM ET ST.
Sign-up for EnteroMedics Reports Third Quarter 2014 Financial Results investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference investment picks
Company demonstrates new 25G Ethernet MAC and PCS LogiCORE IP at Supercomputing 2014 SAN JOSE, Calif.
Sign-up for Xilinx Announces Industry's First Low Latency 25G Ethernet IP for FPGAs to Address Throughput Challenges in Data Center Applications investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) , a clinical-stage biopharmaceutical company whose lead product candidate, eravacycline, is being developed as a broad-spectrum intravenous and oral antibiotic designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced its participation in two upcoming investor conferences: A live audio webcast of the Stifel presentation will be available on the Company's website at http://ir.tphase.com/events.cfm .
Sign-up for Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences investment picks
Strategically Compelling, Financially Attractive Transaction - Attractive market extension of Mid-Atlantic footprint - Second largest bank headquartered in Pennsylvania - Combined #5 ranking in Susquehanna's markets - Strong fit with BB&T's culture and community banking model - EPS accretive and strong IRR WINSTON-SALEM, N.C. and LITITZ, Pa.
Sign-up for BB&T to acquire Susquehanna Bancshares investment picks
bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today reported financial results and operational highlights for the quarter ended September 30, 2014.
Sign-up for bluebird bio Reports Fiscal Third Quarter 2014 Financial Results investment picks
The Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, a pilot initiative, will provide pro-bono oral care for 250-300 Holocaust survivors across nine North American cities MELVILLE, N.Y. , Nov.
Sign-up for Henry Schein and Alpha Omega International Dental Fraternity Answer the White House's Call to Action to Enhance the Quality of Life of Holocaust Survivors investment picks
Moody’s Corporation (NYSE:MCO) today announced that Raymond W.
Sign-up for Moody's Corporation Announces Change to Presentation Time at the Wells Fargo TMT Conference on November 13, 2014 in New York investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2014 and provided an update on its pipeline and CTP-354.
Sign-up for Concert Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Update on CTP-354 Program investment picks
Aradigm Corporation (Nasdaq:ARDM) (the “Company”) today announced that Igor Gonda, Aradigm’s President and Chief Executive Officer, will present an overview of the Company at the Stifel Healthcare Conference 2014 at the New York Palace Hotel in New York, New York on Tuesday, November 18, 2014 at 8:00 am Eastern time.
Sign-up for Aradigm to Present at the Stifel Healthcare Conference 2014 investment picks
Next-Generation MCUs for IoT, Sensor Fusion, Industrial Automation, Motor Control and Wireless Connectivity Applications Will Incorporate New Core SUNNYVALE, Calif.
Sign-up for Spansion Licenses ARM's High-Performance Cortex-M7 Processor investment picks
Kamada Ltd.
Sign-up for Kamada Announces Third Quarter 2014 Financial Results investment picks
Markit Ltd.
Sign-up for Markit Reports Third Quarter 2014 Financial Results investment picks
PORTSMOUTH, N.H. , Nov.
Sign-up for Sprague Resources LP Reports Third Quarter 2014 Results investment picks
BRIDGEVILLE, Pa., Nov.
Sign-up for Universal Stainless to Present at Midwest Investment Conference on November 18th investment picks
Company to Hold Conference Call on November 12, 2014, at 10:00 AM ET / 7:00 AM PT SAN FRANCISCO and SHENZHEN, China , Nov.
Sign-up for Highpower International Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2014 investment picks
MIDDLETOWN, R.I., Nov.
Sign-up for Photo Release -- KVH Offering Videotel's New Ebola Safety Video Free to Mariners investment picks
NAIROBI, Kenya , Nov.
Sign-up for Kenya Power Taps IBM Real Time Data Solutions To Improve Business Performance investment picks
DALLAS , Nov.
Sign-up for Alon USA Partners To Acquire Krotz Springs Refinery From Alon Energy investment picks
Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that Ron Cohen, M.D., President and Chief Executive Officer will present at the Stifel 2014 Healthcare Conference on Tuesday, November 18 at 1:50pm ET.
Sign-up for Acorda Therapeutics to Present at the Stifel 2014 Healthcare Conference investment picks
Ocular Therapeutix (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the third quarter ended September 30, 2014, and provided an update on current business developments.
Sign-up for Ocular Therapeutix™ Reports Third Quarter 2014 Financial Results investment picks
LATHAM, N.Y., Nov.
Sign-up for Plug Power Announces 2014 Third Quarter Results investment picks
RALEIGH, N.C., Nov.
Sign-up for LipoScience Announces 2014 Third Quarter Financial Results investment picks
Multimedia Games Holding Company, Inc. (Nasdaq:MGAM) (“Multimedia Games” or the “Company”) today reported operating results for its fiscal 2014 fourth quarter and full year ended September 30, 2014, as summarized below.
Sign-up for Multimedia Games Reports Fiscal 2014 Fourth Quarter and Full Year Results investment picks
SANTA MONICA, Calif., Nov.
Sign-up for TrueCar Announces Pricing of Follow-on Offering investment picks
MISSISSAUGA, ON , Nov.
Sign-up for KP Tissue Releases Third Quarter 2014 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: EnteroMedics Reports Third Quarter 2014 Financial Results to KP Tissue Releases Third Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent